Ocugen, Inc. (OCGN) Financials

OCGN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 74.7 million 16.3 million
2023-06-30 89.0 million 18.7 million
2023-03-31 96.3 million 20.5 million
2022-12-31 108.6 million 24.6 million

OCGN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -17.1 million 2.2 million
2023-06-30 -21.6 million 2.6 million
2023-03-31 -19.9 million 2.7 million
2022-12-31 -18.9 million 2.7 million

OCGN Net Income

No data available :(

OCGN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 53.5 million - 3.7 million
2023-06-30 70.6 million 1.5 million 3.8 million
2023-03-31 76.7 million 1.1 million 4.0 million
2022-12-31 90.9 million - 4.1 million

OCGN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 256.5 million
2023-06-30 238.3 million
2023-03-31 225.5 million
2022-12-31 220.1 million

OCGN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 3.4 million 6.3 million 9.1 million -
2023-06-30 2.8 million 14.2 million 9.6 million -
2023-03-31 1.6 million 9.6 million 8.2 million -
2022-12-31 2.0 million 17.2 million 6.9 million -

OCGN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 177000
2023-06-30 - 308000
2023-03-31 - 305000
2022-12-31 - 303000

OCGN

Price: $1.28

52 week price:
0.35
2.11

Earnings Per Share: -0.32 USD

P/E Ratio: -1.68

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 4.7 million

Market Capitalization: 469.4 million

Links: